The Effects of Antibiotics on Immunocompromised Patients

Only 6% of people in the trial were immunocompromised. Only 21% had COPD. The median PETA app ratio was 140. These patients were pretty sick. So I think if I were to apply this and starting to look at some of the secondary analysis, probably going to be people that are more severe. Maybe people with a higher CRP, is that something that you'll get at your institution? And those are maybe the folks that I would lean more towards using this on,. Particularly in a shortage situation, we have to be even more judicious than we normally would.